Drug related policies expected to undergo major changes (first part)

Under the incoming Lee Myung-bak administration, scheduled to be inaugurated late next month, the country's pharmaceutical paradigm is expected to experience a major change from that of the incumbent Roh Moo-hyun administration.

The most drastic changes under his reign are likely to be the alleviation or even outright elimination of various regulations against private enterprises.

One of ...